Describe our experience with tocilizumab in the treatment of refractory relapsing polychondritis with ocular involvement. Retrospective consecutive interventional case series that included all patients that received tocilizumab for the treatment of relapsing polychondritis with ocular manifestations. Three cases were selected and the duration of tocilizumab treatment ranged from 1 to 2 years.
View Article and Find Full Text PDF